San Diego, CA – August 19, 2003 –The Center for Commercialization of Advanced Technology (CCAT) today announced that six of its current clients were given additional awards in the form of product development grants and market studies. Distribution of these awards was based on the client’s technology development since joining the CCAT program, the technology’s future commercialization potential and current homeland security & defense needs as determined by the CCAT Executive Board.
“Our latest distribution of grants and services demonstrates our long-term commitment to our clients and the commercialization of homeland defense and security technologies,” said Lou Kelly, Chairman of CCAT.
Winners included the following companies and technologies:
- Intecon – awarded a second CCAT market study for the further commercialization of its Binary Ionization Technology (BITTM), which rapidly decontaminates harmful organisms suspended in air or attached to surfaces and removes contamination utilizing off the shelf hardware. This market study will further explore the potential interest of the first-responder marketplace. As a result of the initial market study provided by CCAT in 2001, Intecon received funding of approximately $5 million from Titan Corporation, a leading prime defense contractor. Titan has exclusively licensed BITTM from Intecon for two years with a follow-on option to purchase.
- EyeTracking – received a $50,000 Product Development Award for the advancement of their unique eye-tracking technology that couples point of gaze information with real-time measures of cognitive workload. With this additional funding, EyeTracking will develop a case study in partnership with a leading supplier of high quality X-ray screening and explosive detection systems. In 2001 EyeTracking was awarded a CCAT market study which uncovered large markets and recommended case studies to help market entry. EyeTracking then received an award for two case studies with two major defense enterprises located in San Diego. These studies have recently completed with compelling results.
- Amaratek – received a $75,000 Product Development Award for further development of their detoxification solution for chemical weapons, which is the first viable decontamination solution safe for use on civilian facilities, open terrain, and people. In 2002 Amaratek was awarded a market study and a $75,000 Product Development Award. The market study determined several viable government and commercial markets. This additional CCAT award will be used to further develop and field test the technology’s capabilities ensuring the fulfillment of a specific Department of Defense need.
- Novatron – received a $75,000 product development award for its Advanced UV Source (AUVS) technology that protects against biological agents and microorganisms. Novatron received a CCAT market study in early 2003, which determined that the technology has significant homeland defense applications and is commercially viable. The recent award will be used to advance product development through testing.
- Polexis – was award a $30,000 Product Development Award to conduct Beta testing of their VIGILYS technology in partnership with the San Diego County EMS. VIGILYS is a software solution that allows federal, state, and local agencies to collaborate prior to, during, and after a crisis. In 2002 Polexis received a market study and a $75,000 Product Development Award from CCAT, which were instrumental in developing the software application as well as identifying potential markets.
- Phasebridge – awarded a CCAT market study for the further commercialization of its fiber-optic transmission module products. The study will help Phasebridge identify as many programs as possible that have a need for their technology. In early 2003, Phasebridge was given a CCAT market study and $75,000 product development award, which were instrumental in evaluation, and product development.
CCAT will be accepting applications for its ninth solicitation beginning in September. For additional information, including applications and deadlines, please visit www.ccatsandiego.org.
Since its inception in July 2001, CCAT has issued 112 awards and services totaling approximately $8.2 million to 62 technology companies, university researchers and government labs.
ABOUT THE CENTER FOR COMMERCIALIZATION OF ADVANCED TECHNOLOGY
CCAT – supported by Congress and funded by the Department of Defense – is a public-private collaborative partnership between academia, industry, and government. Partners include San Diego State University (SDSU) Foundation and Entrepreneurial Management Center, the University of California, San Diego (UCSD) Jacobs School of Engineering and UCSD CONNECT, and Lockheed Martin ORINCON Technologies, Inc. with support from the Space and Naval Warfare Systems Center, San Diego. The consortium-style CCAT intends to bridge the gap that exists between the generators of technology, the Department of Defense and the commercial marketplace. For more information about CCAT, visit www.ccatsandiego.org.